Your browser doesn't support javascript.
loading
Persistence of nevirapine in breast milk after discontinuation of treatment.
Bennetto-Hood, Chantelle; Aldrovandi, Grace M; King, Jennifer R; Woodman, Kyra; Ashouri, Negar; Acosta, Edward P.
Affiliation
  • Bennetto-Hood C; Division of Clinical Pharmacology, University of Alabama at Birmingham School of Medicine, Birmingham, AL 35294-0019, USA.
Clin Infect Dis ; 45(3): 391-4, 2007 Aug 01.
Article in En | MEDLINE | ID: mdl-17599320
ABSTRACT
The objective of this study was to serially quantitate the concentration of nevirapine in breast milk after discontinuation of treatment. Samples were collected from both breasts of a human immunodeficiency virus-infected patient for 3 weeks. Nevirapine was quantifiable for up to 17 days after discontinuation of therapy; total nevirapine concentrations remained above the 90% inhibitory concentration for 6 days, and no differences were observed between breasts.
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents / Nevirapine / Milk, Human Limits: Female / Humans / Pregnancy Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2007 Document type: Article Affiliation country:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents / Nevirapine / Milk, Human Limits: Female / Humans / Pregnancy Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2007 Document type: Article Affiliation country: